Pharmacology of movement Flashcards

1
Q

What are Lewy bodies?

A

intracellular formations enriched in the protein alpha-synuclein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What part of the brain is DaT imaging used on? In terms of Parkinson’s, what does this imaging show?

A

Looks at the striatum

Monitors the dopaminergic nigral cell loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

List some of the features/symptoms of Parkinson’s disease.

A

Frozen facial expression
Flexed posture
Altered (shuffling) gait
Difficulting initiating + stopping movements
Gradual development of micrographia
Non motor features: olfactory dysfunction, depression, sleep disturbance, cognitive dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the name of the scoring scale for disability that is commonly used for PD patients?

A

Schwaband England Activities of Daily Living
100% = independent, no slowness/impairment
0% = vegetative functions (swallowing, bladder + bowel) not functioning

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

List some of the genes implicated in PD.

A
SNCA
LRRK2
GBA
PARK2 and PARK7
PINK1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the result of defects in the SNCA gene?

A

it affects alpha-synuclein
it is a rare defect
duplications or triplications can cause autosomal dominant, familial PD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What does MPTP stand for?

A

Methyl-phenyl-tetrahydropyridine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What converts MPTP to MPP and why is this dangerous?

A

Monoamine oxidase B converts MPTP -> MPP (1-methyl-4-phenylpyridine)
This is dangerous as MPP is neurotoxic for dopaminergic neurones and can cause mitochondrial toxicity
Does this by inhibiting complex I in the mitochondrial respiratory chain - this reduces ATP production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Name the 3 main dopaminergic pathways in the CNS.

A
  1. Mesocortical - ventral tegmental area –> prefrontal cortex
  2. Nigrostriatal - substantia nigra pars compacta –> dorsal striatum
  3. Mesolimbic - ventral tegmental area –> ventral striatum
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What type of receptors are dopamine receptors?

A

GPCRs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What receptor subtypes belong to the D1 and D2 families respectively?

A

D1 family = D1, D5

D2 family = D2, D3, D4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is L-Dopa combined with peripherally and why?

A

DOPA decarboxylase inhibitors (Carbidopa and benserazide)
This prevents the conversion of L-Dopa to dopamine in the periphery (outside CNS)
This prevents adverse effects such as nausea and hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Give examples of dopamine agonists.

A
  • ropinirole
  • pramipexole
  • rotigotine
  • pergolide
  • bromocriptine
  • cabergoline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the route of administration of rotigotine?

A

transdermal patch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the route of administration of apomorphine?

A

infusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Why might a clinician prescribe MAOB inhibitors to a PD patient?

A

to preserve residual dopamine against oxidation

17
Q

Give two examples of MAOB inhibitors.

A

Rasagiline

Selegiline

18
Q

Why might a clinician prescribe anticholinergic/antimuscarininc compounds to a patient with PD?
Give examples of such compounds.

A

Dopamine loss can lead to hyperactivity in cholinergic cells

Examples = orphendarine, procyclidine, trihexyphenidyl

19
Q

Why might amantadine be an appropriate drug to prescribe to someone with PD?

A

it inhibits dopamine reuptake and increases dopamine release

20
Q

Give examples of motor complications associated with L-Dopa use.

A

“on-off” effect
“wearing off”/tolerance
dyskinesia, dystonia

21
Q

On what chromosome is the Huntingtin gene found?

A

Chromosome 4

22
Q

How is the Huntingtin gene mutated in Huntington’s disease?

A

gene presents with an abnormal number of repeats of glutamine (CAG codon)
An abnormal gene will contain >36 repeats leading to a GAIN of function (the mutated protein will aggregate inside of cells)

23
Q

What physical changes to the brain occur in Huntington’s?

A

Cortical atrophy
Striatal degeneration
Loss of medium size spiny neurones

24
Q

What are some of the mechanisms underlying neurodenegeration in Huntington’s?

A

Excitotoxicity (due to increases glutamate)
Loss of neurotrophic facotrs
Accumulation of aggregates of mutant huntingtin protein
Dysregulation of transcription
Increased oxidative stress
Abnormalities in axonal transport
Synaptic abnormalities

25
List some of the symptoms of Huntington's.
``` Choreic movement Gait abnormalities Lack of coordination Cognitive impairment Psychiatric disturbances Sleep disturbance Weight loss ```
26
When might a COMT-inhibitor be prescribed for Parkinson's? Give examples of these drugs.
Usually used in combination with L-dopa, so probably prescribed when L-dopa becomes less effective Examples: tolcapone, entacapone
27
Give examples of non-motor side effects of L-Dopa.
- N+V - Postural hypotension - Psychosis - Impulse-control disorders - Excessive day time sleepiness
28
What are the different surgical approaches to treating PD?
- stimulation of subthalamic nucleus (DBS) | - pallidotomy/thalamotomy
29
Give example(s) of vesicular amine transporters used to treat Huntington's.
Tetrabenazine
30
Give example(s) of antidopaminergic/antipsychotic drugs used to treat Huntington's.
Haloperidol | Olanzapine
31
Give example(s) of antidepressants used to treat Huntington's.
Imipramine | Amitriptyline